Lower respiratory tract infection
Not recruitingStudy on the Safety and Immune Response of mRNA-1345 and mRNA-1365 for Infants with Acute Lower Respiratory Infection Aged 5 to 24 Months
Study on the Safety and Immune Response of mRNA-1345 and mRNA-1365 for Infants with Acute Lower Respiratory Infection Aged 5 to 24 Months
- Disease:Lower respiratory tract infection
- Substances:MRNA-1345MRNA-1365-RSV+5
Latvia- Participants:0–17 years · Healthy volunteers
- Substances:MRNA-1345
- Sponsor:Moderna Therapeutics Inc.


